This site is intended for U.S. healthcare professionals only
INFUVITE Multiple Vitamins for Injection

INFUVITE Multiple Vitamins for Injection

PI: Adult PI: Pediatric

A trusted choice among Healthcare Professionals for more than 10 years.

Patients receiving parenteral nutrition should also receive a daily dose of multivitamins from the start of therapy, per A.S.P.E.N. Guidelines1

Full portfolio of injectable multivitamin formulations

  • Aluminum Content
    • Not more than 30 mcg/L for INFUVITE Pediatric Multiple Vitamins. Not more than 70 mcg/L for INFUVITE Adult Multiple Vitamins. (Combined vials 1 and 2.)
  • Zero preservatives

1. A.S.P.E.N. Board of Directors. JPEN J Parenter Enteral Nutr 2002;26(1 Suppl):1SA–138SA.


  • INFUVITE Multiple Vitamins for Injection are for intravenous infusion after dilution only.
  • INFUVITE Adult Multiple Vitamins & Pediatric Multiple Vitamins are also indicated in other situations where administration by the intravenous route is required. Such situations include surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states, which may provoke a "stress" situation with profound alterations in the body's metabolic demands and consequent tissue depletion of nutrients.
  • INFUVITE Adult Multiple Vitamins for Injection are indicated as a daily multivitamin maintenance supplement for adults and children aged 11 and older receiving parenteral nutrition.
  • INFUVITE Pediatric Multiple Vitamins for Injection are indicated as a daily multivitamin maintenance dosage for infants and children up to 11 years of age receiving parenteral nutrition.

Important Risk Information

  • INFUVITE Adult and Pediatric Multiple Vitamins for Injection is contraindicated in patients who have an existing hypervitaminosis, or a history of hypersensitivity due to any vitamins or excipients contained in this formulation.
  • Allergic reactions have been known to occur following intravenous administration of thiamine and vitamin K. The formulation is contraindicated prior to blood sampling for detection of megaloblastic anemia, as the folic acid and the cyanocobalamin in the vitamin solution can mask serum deficits.
  • Caution should be exercised when administering INFUVITE Multiple Vitamins for Injection to patients on warfarin sodium-type anticoagulation therapy. Periodic monitoring of prothrombin time/INR response is essential in determining the appropriate dosage of anticoagulant therapy.
  • If this formulation is the only source of vitamins for a long period of time, blood concentrations of each of the vitamins should be monitored, particularly vitamins A, C, D, and folic acid, to determine if deficiencies are occurring. There have been rare reports of anaphylactoid reactions following intravenous doses of thiamine.
  • Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum

Please see full prescribing information

USMP/78/17-0008(1) 10/18